SERUM T3 AND T4 LEVELS DURING ADMINISTRATION OF ANTITHYROID DRUGS IN HYPERTHYROIDISM

dc.contributor.authorVELA, AG
dc.contributor.authorVARGAS, EG
dc.contributor.authorRUELAS BALBANEDA, G
dc.date.accessioned2026-05-28T16:50:45Z
dc.date.issued1977
dc.description.paginacion90 - 91
dc.description.procedenciaLOC
dc.format.discursoResumen de reunión
dc.format.extent2
dc.identifier.issn0034-8376
dc.identifier.urihttps://ahcm.cinvestav.mx/handle/ahcm/28349
dc.language.isoEspañol
dc.numero.secuencia28346
dc.publisherUNIV GUANAJUATO,FAC MED LEON,GUANAJUATO,MEXICO
dc.relation.ispartofseriesVol. 29 No. 1
dc.source.revistafuenteREVISTA DE INVESTIGACION CLINICA
dc.subjectSERUM, ADMINISTRATION, ANTITHYROID, DRUGS, HYPERTHYROIDISM
dc.subject.categoriaprincipalCIENCIAS MEDICAS
dc.subject.disciplinaCIENCIAS CLINICAS
dc.subject.subdisciplinaPATOLOGIA CLINICA
dc.titleSERUM T3 AND T4 LEVELS DURING ADMINISTRATION OF ANTITHYROID DRUGS IN HYPERTHYROIDISM
dc.title.alternativeREV INVEST CLIN

Files